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Effects of Ohio Opioid Prescribing Policy on Postsurgical Prescriptions Following
Sports Procedures
Joseph Henningsen MD‡; Scott Huff MD¤; Andrew Schneider MD¤; Fady Hijji MD¤; Andrew Froehle
PhD¤; Anil Krishnamurthy MD¢
‡Wright State University Orthopedic Surgery Residency, ¤Wright State University Department of
Orthopedic Surgery, ¢Department of Orthopedic Surgery Dayton VA Medical Center
Background: Prescribed opioid medication after orthopedic sports surgery has been shown to
exceed patient requirements. In 2017, as a response to the opioid epidemic, Ohio passed Opioid
Prescribing Guidelines (OPG) limiting narcotic prescriptions for acute pain. This study sought to
evaluate the effects of the OPG on prescribing behavior of orthopedists following knee arthroscopy
(KA), shoulder arthroscopy (SA), and anterior cruciate ligament reconstruction (ACLR). Methods:
An institutional database was queried to calculate morphine equivalent dose (MED) prescribed at
discharge, acute follow-up (<90 days), and chronic follow-up (>90 days) and compare MED pre- and
post-OPG. Cases were identified over a 2-year period starting 1 year prior to OPG implementation.
Individual surgeon data were tracked to control for inter-surgeon variability. Results: A total of
1663 patients were included in the analysis. Demographic variables were similar pre- and post-OPG
for each procedure group. With all surgeons included, average discharge MED decreased
significantly for all procedures from pre- to post-OPG. Surgeons qualified for individual analysis if
they had at least 10 surgeries pre- and post-OPG. Of qualifying providers, 80% of KA, 25% of SA,
and 0% of ACLR surgeons reduced discharge MED prescribed post-OPG. MED prescribed during
follow-up was largely unaffected by implementation of the OPG. Conclusion: Average discharge
morphine equivalent dose (MED) prescribed after SA, KA, and ACLR decreased following the
implementation of the OPG. The MED reduction effect of the OPG was the greatest in magnitude
after SA, and SA was the only surgery that showed MED reductions that persisted during acute
follow up. Opioid prescriptions beyond 90 days postoperatively were unchanged by the OPG for all
surgeries. Policy that restricts postoperative opioid prescriptions can be an effective, but
incomplete method to address the opioid crisis. Key Words: opioids, sports, policy
_________________________________________________________________________________________________________________
INTRODUCTION
From 1996 – 2004, political pressure and
public policy in the United States encouraged
opioid utilization for the treatment of pain
without regulation.1–3 This led to an
exponential increase in narcotic prescriptions
and contributed to the development of the
current opioid crisis. 4,5 In response to rapidly
rising mortality rates related to drug
overdose, states have begun legislating policy
towards the monitoring and reduction of
prescription opioids. In 2017, one such piece
of legislation was passed in the state of Ohio
to limit opioid medications prescribed for
acute pain.6 Known as the Ohio Opioid
Prescribing Guidelines (OPG), it stipulated
that no more than seven days of opioids may
be prescribed, and that the total morphine

equivalent dosage (MED) of the prescription
cannot exceed an average of 30 MED per day.
Appropriate documentation of specific
exemptions allows health care providers to
prescribe opioids in excess of these limits.6
Whale et al.7 previously analyzed the effect of
the OPG on opioid prescribing behavior
following total joint arthroplasties. However,
the use of opioid prescriptions to manage
postoperative pain is also standard practice
for orthopedic sports surgeons.8,9 Orthopedic
intervention has been shown to be costeffective for a multitude of different
indications for both knee and shoulder
pathologies.10,11 The frequency of these
interventions has been increasingly common
over the past 30 years.8,12,13 Despite
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widespread knowledge of the opioid
epidemic, sports surgeons continue to
prescribe opioid quantities that are in excess
of what the typical patient requires.14,15 Thus,
the efficacy and clinical effect of the OPG
regulations on orthopedic sports surgeons
merits objective analysis.
The purpose of this study was to
retrospectively analyze the OPG restrictions
and their effect on the prescribing patterns of
orthopedic sports surgeons. Prescriber
behavior was analyzed before and after the
initiation of the OPG, following three common
sports procedures: knee arthroscopy (KA),
shoulder arthroscopy (SA), and anterior
cruciate ligament reconstruction (ACLR). We
hypothesized that the new guidelines for
acute pain management would have a
significant effect on the prescribing practices
of orthopedic providers by reducing MED
prescribed at discharge, at two follow-up time
points, and in total.
METHODS
All study protocols were reviewed and
approved by the university’s Institutional
Review Board. Data were retrospectively
obtained from a single hospital network that
included five hospitals, similar to a previously
published protocol.7 Briefly, Structured Query
Language (SQL) programming was used to
extract data directly from the network’s
electronic medical records (EMR; Hyperspace
2018; Epic Systems Corporation). Cohorts
were defined by surgery performed within 1year date ranges surrounding August 31,
2017, the date the OPG went into effect. The
pre-OPG cohort was defined as surgeries that
occurred from September 1, 2016 to August
31, 2017, and likewise, the post-OPG cohort
was defined as surgeries that occurred from
September 1, 2017 to August 31 2018. An
institutional Open Surgical Procedure code
was used to document every surgery
performed within the 5-hospital system. This
code was used to identify outpatient surgeries
that were coded as Shoulder Arthroscopy
(SA), Knee Arthroscopy (KA), and ACL

Reconstruction (ACLR). KA was separate from
ACLR due to the expected increased pain after
ACLR compared to KA. A total of 1963
surgeries were retrospectively identified.
Exclusion criteria included: age less than 18
years, any procedure found to have
incomplete data, surgical diagnosis of septic
arthritis, surgical diagnosis of degenerative
knee pathology, revision ACL reconstruction,
or any inpatient stay after surgery. The
primary operative surgeon was de-identified
and assigned a unique identifier. Surgeon ID
was included in pooled analyses to control for
variability of prescribing patterns between
providers. Surgeons with <10 procedures in
either the pre-OPG or post-OPG time periods
were excluded from analysis of individual
surgeon behaviors but were retained in the
pooled opioid prescription analysis (see
statistical analysis details below). The above
method of identifying and analyzing surgical
data within this hospital system has been
tested and shown to be accurate.7
Patient-level variables were collected,
including age, sex, BMI, and Charlson
Comorbidity Index (CCI). The primary
outcomes were oral MED prescribed at
discharge and follow-up. All opioids were
converted to oral MED using the conversion
formula provided by the Ohio Board of
Pharmacy.16 Follow-up duration was split into
90-day follow-up (acute) and greater than 90
days follow-up (chronic). Total MED
prescriptions for a given surgery were defined
as discharge MED + acute MED + chronic MED.
Only opioid prescriptions written by
orthopedic surgeons, residents, or advance
practice practitioners within the hospital
system were included in the analysis. The
exclusion of non-orthopedic providers was
performed to maximize data accuracy and
allow for tighter control of inter-prescriber
variability, although it may not have captured
the full scope of each patient’s complete
access to opioid prescriptions during the
study period.

Journal of Sports Medicine and Allied Health Science | Vol. 8 | Issue. 3 | Fall 2022
Published by ScholarWorks@BGSU,2022

2

Henningsen, Huff, Schneider, Hijji, Froehle, & Krishnamurthy. Ohio Opioid Prescribing Policy Effects on Orthopaedic Patients

Statistical.Analysis
Each sports surgery group was analyzed
separately, but the same analysis methods
were used for each. All statistical analysis was
performed in SAS 9.4 (SAS Institute, Cary, NC)
with significance set to α=0.05. For each
surgical procedure, patient characteristics
were compared between the pre- and postOPG cohorts using Wilcoxon-Mann-Whitney
tests for continuous and ordinal variables, and
chi-square tests for frequency distributions.
We calculated effect size using Cohen’s d for
continuous data, Cramer’s V for frequency
data, and following Grissom and Kim for
ordinal data.17 Common language effect size
(CL; also called probability of superiority) was
calculated for each comparison.18
For each surgical procedure, pooled MED data
from all surgeons were analyzed for pre- to
post-OPG differences. Analysis of covariance
(ANCOVA), controlling for surgeon ID, was
used to test for differences in MED pre- and
post-OPG means and standard deviations (SD)
at all time points. This approach controlled for
possible effects of randomness and effects of
variation in surgeon prescribing habits,
workflow, and case load in response to the
OPG implementation. Sub-analyses included
examining only those patients with greater
than 0 MEDs prescribed during the follow-up
time points, and the percentage of patients
that received any opioid prescription during
each follow-up period was also assessed.
Individual prescriber patterns were also
compared between time periods within
qualifying surgeons (≥10 observations of the
relevant procedure in both the pre- and postOPG time periods). Due to sample size, only
discharge prescriptions were used for
prescriber-specific analysis. Changes in
individual prescriber MED levels were
analyzed using Wilcoxon-Mann-Whitney
tests, Cohen’s d, and CL. Changes in individual
prescriber prescription variability were also
qualitatively
assessed
by
comparing

coefficients of variation (CV) pre- and postOPG.
RESULTS
A final combined cohort of N=1663 outpatient
orthopedic sports surgeries were included in
the final sample (KA: N=519, SA: N=1033,
ACLR: N=111). Of the KA cases, 494 (95%) had
a surgical diagnosis of meniscal injury with
the remaining 25 patients having diagnoses
related to cartilage pathology. Indications for
SA were more variable, with rotator cuff
repair (60%) making up the majority of the
surgical diagnoses, followed by labral
pathology (15%), impingement (10%) and
instability (5%). The diagnosis of pain made
up the remainder of surgical diagnoses for the
SA group (10%).
Sample size, demographics, and comorbidities
comparing each surgery group pre- and postOPG are presented in Table 1. Surgery
cohorts were comparable in terms of
demographics and comorbidities both preand post-OPG. Of note, the ACLR procedure
had a substantially smaller sample size when
compared to KA and SA, which limited
subgroup analyses.
Postoperative.MED.Prescribed
MEDs prescribed at discharge were
significantly
reduced
after
OPG
implementation for all surgeries studied (preOPG mean±SD vs. post-OPG mean±SD: KA:
262.0±12.1 vs. 188.4±11.4, P<0.01; SA:
566.4±12.2 vs. 314.50±10.4, P<0.01; ACLR:
573.4±34.7 vs. 428.5±35, P<0.01)
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Variable
Pre-OPG
Post-OPG
Pb
ESc
CLc
Knee
Sample (N)
244
275
Arthroscopy
Age (y)
14.4 ± 54.5
54.0 ± 13.9
0.61
0.04
0.51
Sex (%F)
57%
49%
0.11
0.07
0.52
BMI (k∙m-2)
32.4 ± 7.5
33.1 ± 8.0
0.52
0.09
0.53
CCI
2 (0-3)
1 (0-2)
0.08
0.16
0.54
Shoulder
Sample (N)
438
595
Arthroscopy
Age (y)
53.5 ± 15.8
53.6 ± 14.7
0.74
<0.01
0.50
Sex (%F)
40%
30.5 ± 14.7
0.41
0.03
0.51
BMI (k∙m-2)
30.0 ± 6.4
43%
0.07
0.08
0.52
CCI
1 (0-3)
1 (0-3)
0.73
0.05
0.51
ACL
Sample (N)
57
54
Reconstruction Age (y)
27.4 ± 9.7
30.3 ± 9.9
0.11
0.30
0.58
Sex (%F)
53%
46%
0.57
0.06
0.52
BMI (k∙m-2)
27.6 ± 5.5
28.8 ± 7.3
0.62
0.19
0.55
CCI
0 (0-0)
0 (0-0)
0.76
<0.01
0.50
Table 1. Sample Characteristics for Knee Arthroscopy, Shoulder Arthroscopy, and ACL Reconstruction Patients. (a.
presented values are mean ± SD for ratio data [ age, BMI], median ± IQR for interval data [ CCI], and frequencies for the
nominal variable sex; b. P-values: Wilcoxon-Mann-Whitney tests [continuous data] or chi-square tests [nominal data]; c.
effect size estimates [ES]: continuous data = Cohen’s d, frequency data = Cramer’s V, CL: common language effect size)

However, SA was the only procedure group to
show statistically significant reductions in
MED prescribed during acute follow-up (preOPG: 242.1±19.7 vs. post-OPG: 186.1±16.8,
P=0.03). Likewise, SA showed reductions in
total
MED
per
procedure
after
implementation of the OPG (pre-OPG:
863.8±32.4 vs. post-OPG: 543.6±27.7, P<0.01)
[Figure 1]. No other statistically significant
differences were found for MED prescribed
after KA, SA, or ACLR during acute or chronic
follow up (for each, P≥0.10). Similarly, no
statistically significant differences were found
when the frequency of patients receiving
opioid prescriptions during follow up periods
was compared pre- and post-OPG (for each,
P≥0.09) [Figure 2].

Figure 2. Percentage of Patients Receiving any Opioid
Prescription (black bars represent pre-OPG and white
bars represent post-OPG patients.)

Finally, subgroup analysis of only those
patients receiving an opioid prescription
during each follow-up period found no
significant differences in MED prescribed per
patient from pre- to post-OPG (for each,
P≥0.07). These findings of non-significance
included knee arthroscopy patients receiving
follow-up prescriptions, despite increases in
adjusted mean MED of 37% at acute follow-up
(P=0.17) and 148% at chronic follow-up
(P=0.07) [Figure 3].

Figure 1. Pre-OPG and Post- OPG Opioid Prescriptions
(MED) Across All Patients and All Prescribers (bar
represent means adjusted for prescriber (ANCOVA), and
whiskers represent standard errors)
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Figure 3. Sub-Analysis of Only Patients Who Received
Opioid Prescriptions. Black bars represent Pre-OPG and
white bars represent Post-OPG patients. Asterisks
indicate
that
the
Post-OPG
adjusted
mean.is.significantly.lower.than.the.Pre-OPG.adjusted
mean (*P<0.05;**P<0.01).

Individual.Surgeon.Analysis
Eight unique surgeons met the sample size
criteria for individual analysis for one or more
of the procedures. Assigned surgeon IDs are
consistent across procedures for the following
results and related figures. In all, these
analyses included five surgeons performing
KA, four surgeons performing SA, and two
surgeons performing ACLR [Table 2].

ranged from 15.8% to 25.4% (for each,
P≤0.01) with moderate effect sizes (Cohen’s d
range: 0.25 to 0.54; CL range: 0.57-0.66). The
remaining KA surgeon exhibited no change in
prescribed MED post-OPG (3.3% increase;
P=0.41). Regarding SA, only one of the four
surgeons (S1) exhibited a substantial,
significant reduction in prescribed opioids of
59.0% [Figure 5], with a large effect size
(P<0.01; Cohen’s d: 2.23; CL: 0.94). The other
three surgeons performing SA exhibited
negligible reductions of 0.2% to 2.4% (for
each, P≥0.41). Neither ACLR surgeon
demonstrated any meaningful change in
prescribed MED at discharge post-OPG (S8:
3.9% increase, P=0.44; S2: 2.0% decrease,
P=0.43) [Figure 6].

Table 2. Number of procedures by surgeona
Surge
on ID

NKNEE

NSHOULDER

NACL

NTOTAL

S1

---

381

---

381

S2

50

223

33

306

S3

---

241

---

241

S4

79

69

---

148

S5

68

---

---

68

S6

66

---

---

66

S7

65

---

---

65

S8

---

---

33

33

a.

Figure 4. Mean Pre-OPG and Post-OPG Discharge MEDs
for Each Surgeon Performing Knee Arthroscopy. Black
bars are for Pre-OPG patients, white bars are for PostOPG patients. Asterisks indicate that the Post-OPG mean
is significantly lower than the Pre-OPG mean
(*P<0.05;**P<0.01).

Includes only surgeons eligible for
individual analysis for one or more
procedures. See text for eligibility criteria.

Of the five surgeons performing KA, four (S2,
S5-S7) exhibited substantial, significant
prescription MED reductions at discharge
post-OPG [Figure 4]. Percent reductions

Figure.5..Mean.Pre-OPG.and.Post-OPG.Discharge
MEDS.for.Each.Surgeon.Performing.Shoulder.
Arthroscopy..Asterisks.indicate.that.the.PostOPG.mean.is.significantly.lower.than.the.PreOPG.mean.(*P<0.01;**P<0.01).
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prescribing metrics beyond 90 days follow-up
for any of the procedures.

Figure 6. Mean Pre-OPG and Post-OPG discharge MEDs
for Each Surgeon Performing ACL reconstruction. Black
bars are for Pre-OPG patients, white bars are for PostOPG patients. Asterisks indicate that the Post-OPG mean
is significantly lower than the Pre-OPG mean
(*P<0.05;**P<0.01).

Finally, there were no consistent patterns of
change in prescription variability from pre- to
post-OPG, as determined by percent changes
in CV, ranging from -29% to +52%. Within KA,
three surgeons increased the variability of
their prescriptions, whereas two decreased.
In SA, two increased and two decreased, while
in ACLR one increased and the other
decreased prescription variability. Of the two
surgeons qualifying under more than one
procedure, one (S4) became consistently
more variable following the start of the OPG
(+32% in KA, and +52% in SA), whereas the
other (S2) showed marginally more
variability in KA prescriptions (+9%), but
slightly less variability for SA (-7%) and ACLR
(-8%).
DISCUSSION
Ohio, like numerous other states, 19–22 recently
initiated new legislation in response to the
opioid epidemic. In the present study, analysis
of 1,663 primary, outpatient sports surgeries
demonstrated that implementation of the OPG
was related to a statistically significant
decrease of MED prescribed at discharge for
all studied procedures. In the case of SA, the
reduction in MED prescribed per procedure
after OPG implementation persisted during
acute follow-up and resulted in a statistically
significant drop in the total MED prescribed
per procedure. This same effect was not
observed for KA or ACLR. Importantly, the
OPG also had no significant effect on opioid

The opioid epidemic that the United States is
facing today is complex, with high rates of
chronic opioid use and drug overdose
mortalities.23 Several recent studies have
presented data illustrating the propensity for
restrictive policy to decrease opioids
prescribed after common orthopedic
surgeries. A theoretical benefit of these
restrictions on acute opioid prescriptions is a
downstream reduction in chronic use.
However, none of these studies present data
beyond 90 days of follow-up.24–26 Our results
show that chronic opioid use did not decrease
as a result of the Ohio OPG in the
postoperative orthopedic sports patient
population. The OPG had no measurable effect
on MED prescribed per procedure, percentage
of patients receiving opioids nor the MED
prescribed per patient beyond 90 days
postoperatively. This is not to say that the OPG
is without substantial benefits, which include
decreased discharge MED across surgeries
and decreased total MED after SA. Opioids
prescribed in excess of a patient’s
requirements have been shown to have the
potential to lead to misuse of excess opioids
by the patient or others in the population.27
Reduction in prescribed opioids at discharge
to a more appropriate level could reduce the
broader potential for recreational use and
abuse.
Our results in Ohio are similar to those that
have been published on data from another
state, Rhode Island, showing that policy can
effectively reduce opioids prescribed at
discharge after orthopedic procedures.24,25
Even without a reduction in chronic use,
ideally, this reduction in MED at discharge is
large enough in magnitude to reduce total
MED prescribed. However, the present study
found that a reduction in total MED prescribed
over the entire follow up course was only seen
for SA. No change in total MED prescribed
after KA and ACLR was observed. Several
reasons may explain why the total MED
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decrease was only found in the SA cohort.
Other studies have shown SA patients to
require
higher
MED
postoperatively
compared to KA patients (300 MED versus
200 MED respectively),9,15 and a similar
pattern was observed in the present study’s
data. Restrictions on opioids may have a
larger effect on surgeries that are more
painful which, thus, have overall higher a
priori levels of opioid prescription. At the
same time, procedures such as KA that are less
opioid-heavy to begin with, may have less
room for decrease, and thus less apparent
prescriber response to state guidelines.
Individual provider analysis demonstrated
heterogeneity between orthopedic surgeons
regarding each surgeon’s response to the OPG
restrictions. Four of the five qualifying
surgeons in the KA procedure cohorts had
statistically significant reductions in MED
prescribed at discharge. This was in stark
contrast to SA procedures, where only a single
surgeon out of the qualifying four
demonstrated a decrease; this SA surgeon’s
decrease in MED prescriptions post-OPG was
the largest in magnitude for any surgeon in
any of the analyzed procedures (Cohen’s d:
2.23; CL: 0.94). Surgeon heterogeneity in MED
reductions from pre- to post-OPG alone is an
interesting finding in our study, but our data
also showed wide disparities in terms of how
variable each surgeon’s prescriptions were
from patient to patient. Although not the
primary outcome of the study, we found that
some prescribers increased their patient-topatient variability from pre- to post-OPG
while others saw this variability decrease. It is
possible that the OPG prompted some
surgeons to adjust narcotic prescription
dosing on a patient-by-patient basis
(increased variability) while others adjusted
narcotic prescriptions more broadly to
comply with the OPG restrictions (decreased
variability). Reasons for this heterogeneity
can only be speculated upon, as this was not
the primary goal of this study; however, this
finding should guide further research into

individual prescriber response to narcotic
prescriber
policy
and
restrictions.
Understanding
surgeon
response
to
restrictions could help guide the creation of
more effective policy in the future.
The
heterogeneity
between
different
surgeons’ responses discussed above
highlights the importance of controlling for
prescriber when assessing the effects of
opioid policy. This prescriber heterogeneity
was seen after a similar analysis of opioid
prescribing
habits after total
joint
arthroplasty.7 To our knowledge, this paper is
the first to control for prescriber
heterogeneity when analyzing the effects of
opioid policy on opioid prescriptions after
orthopedic sports surgeries.
LIMITATIONS
A limitation of this analysis is that it did not
include an evaluation of changes in workflow,
local anesthesia, and other oral analgesics
pre- and post-OPG implementation. The
authors acknowledge that these factors and
others could affect why a particular surgeon’s
practice was or was not changed by the OPG.
Another significant limitation of the study is
the inability to account for opioid
prescriptions outside the hospital system
available. Patients may have obtained opioids
outside the available EMR, including illegally.
Additionally, our methods did not assess for
patient history of opioid use. Sample size
limitations were also encountered with
subgroup analyses and limited our
conclusions. Despite having over 1,500 total
patients, some subgroups had fewer than 25
patients for analysis. In some of those cases,
even large differences were not statistically
significant, which may indicate these analyses
being underpowered [e.g., see Figure 3A and
results pertaining to follow-up MED in KA
patients]. Finally, this study showed reduction
in pain medication without assessing patient
pain levels or patient-reported outcome
measures. Thus, no conclusions can be made
about the effects of the OPG on adequacy of
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pain control, or on patient satisfaction after
the orthopedic sports procedures. Although
there was a reduction in discharge opioids
prescribed, there may have been a
corresponding increase in patient calls and
clinic visits. These variables would be better
addressed with a prospective study
measuring the effects of opioid policy such as
the OPG.

consequences of policy such as the OPG. The
opioid crisis cannot be addressed with a single
policy, but, rather, will require a collaborative
effort
between
disciplines
including
physicians, patients, healthcare systems and
policy makers. Research is needed to
understand how to improve upon current
policies and create new interventions within
and across disciplines.

IMPLICATIONS
Our results illustrate that statewide policy like
the OPG can play a role in reducing opioids
prescribed after some orthopedic procedures,
but the magnitude of the effect is perhaps
more dependent on the prescribing practices
of the surgeon prior to legislation enactment.
The study was designed so that the results can
be applied on an individual prescriber basis,
across healthcare systems and on a policy
level. As postoperative recovery in orthopedic
sports
patients
moves
away
for
pharmacology,
the
need
for
a
multidisciplinary
approach
including
therapists and athletic trainers increases.
Restrictions like the OPG may decrease opioid
burden while increasing the opportunity for
alternatives
including
biofeedback
techniques, electrophysiology and other
therapy techniques to maximize patient
recovery and return to play. Therefore, the
results illustrate the importance for a
multidisciplinary approach to orthopedic
sports surgery including addressing pain
control
alternatives,
surgeon/patient
education and drug monitoring programs.

CONCLUSION
In conclusion, the 2017 Ohio Opioid
Prescribing Guidelines (OPG) led to a clinically
substantial and statistically significant drop in
morphine equivalent dose (MED) prescribed
at discharge after shoulder arthroscopy, knee
arthroscopy, and ACL reconstruction. This
reduction was substantial enough after
shoulder arthroscopy to show a total
reduction in MED prescribed in the six months
following the procedure. Conversely, chronic
opioid prescriptions were shown to be largely
unaffected by the OPG. Heterogeneity in
individual surgeon responses to the OPG after
each surgery was substantial. Overall,
legislation like the OPG can be an effective but
incomplete method to address the role of
orthopedic pain relief prescriptions in the
opioid crisis.

FUTURE.RESEARCH
There remains significant room for
improvement in how we address the opioid
crisis without sacrificing patient care and pain
control. As discussed above, comparing
patient reported pain outcome scores after
common orthopedic surgeries would help
understand how restrictions directly affect
patient symptoms. Also, studies analyzing
policy effect on healthcare costs, patient
return to sport, and healthcare systems would
allow for analysis of any unintended
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